重复经颅磁刺激预防卒中后痉挛的疗效:一项假刺激对照试验
这项双盲随机假刺激对照试验纳入70例早期亚急性卒中患者,比较低频rTMS与假刺激预防上肢痉挛的效果。rTMS组在1个月和3个月时痉挛评分更低,握力、疼痛、功能独立性和生活质量更优;假刺激与1个月和3个月时多个关节痉挛风险升高相关。
要点
- 低频rTMS组在1个月和3个月时所有评估的上肢关节痉挛评分显著低于假刺激组(P=0.001)。
- 假刺激与1个月时肩关节痉挛风险升高相关(OR 8.29,95%CI 1.95–35.27,P=0.04)。
- 5例患者出现头痛和头晕等轻微不良事件。
核心结论
- 低频rTMS作用于对侧初级运动皮层可显著预防早期亚急性卒中患者痉挛,改善运动恢复、减轻疼痛、改善功能结局和生活质量,支持其作为早期卒中康复中有前景的辅助治疗。
研究设计与样本
- 双盲、随机、假刺激对照试验,纳入70例早期亚急性卒中(7–30天)患者,随机分为低频rTMS组(n=35)和假刺激组(n=35),均接受标准治疗。
- rTMS方案为1 Hz、1000个脉冲、90%静息运动阈值,作用于对侧初级运动皮层,共3次。
主要发现
- rTMS组在1个月和3个月时所有评估的上肢关节痉挛评分显著降低(P=0.001),握力改善(P=0.01),疼痛预防(P=0.001)。
- rTMS组1个月时卒中影响量表3.0在日常生活活动、移动能力、手功能、社会参与和恢复方面增益更大(P=0.001)。
- rTMS组3个月时功能独立(改良Rankin量表)显著更好(P=0.006)。
- 二元logistic回归显示,假刺激与1个月时发生痉挛的更高odds相关:肩关节OR 8.29(95%CI 1.95–35.27,P=0.04),肘关节OR 7.62(95%CI 1.69–34.35,P=0.08),腕关节OR 5.18(95%CI 1.60–16.78,P=0.06)。
- 3个月时假刺激仍具预测性,肩关节OR 15.3(95%CI 8.26–28.43)、肘关节OR 13.43(95%CI 3.94–45.78)、腕关节OR 19.9(95%CI 4.9–80.96)、手指OR 26.25(95%CI 5.19–132.87),均P=0.001。
关键数值与推荐
- 主要结局为采用改良Modified Ashworth量表评估的上肢痉挛。
- 次要结局包括握力、医学研究委员会量表评估的肌力、视觉模拟量表评估的疼痛、改良Rankin量表和卒中影响量表3.0。
临床怎么用
- 原文结论认为低频rTMS可作为早期卒中康复中有前景的辅助治疗,支持其作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Stroke, Ahead of Print. BACKGROUND:Poststroke spasticity significantly impairs recovery, yet preventive strategies remain limited. This study evaluated the effectiveness of repetitive transcranial magnetic stimulation (rTMS) in reducing the development and severity of spasticity in patients with early subacute stroke, offering a possible early intervention.METHODS:In this double-blind, randomized, sham-controlled trial, 70 patients with early subacute stroke (7–30 days) were randomized to receive 3 sessions of low-frequency (1 Hz, 1000 pulses at 90% resting motor threshold) rTMS over contralesional primary motor cortex (n=35) or sham stimulation (n=35), alongside standard care. The primary outcome was upper-limb spasticity assessed using the modified Modified Ashworth Scale. Secondary outcomes included handgrip strength, muscle power assessed by the Medical Research Council scale, pain assessed by the Visual Analogue Scale, modified Rankin Scale, and Stroke Impact Scale 3.0.RESULTS:rTMS therapy significantly lowered spasticity scores at 1 and 3 months across all assessed upper-limb joints (P=0.001), improved handgrip strength (P=0.01), and prevented pain (P=0.001). Stroke Impact Scale scores at 1 month showed greater gains in activities of daily living, mobility, hand function, social participation, and recovery in the rTMS group (P=0.001). Functional independence (modified Rankin Scale) was significantly better in the rTMS group (P=0.006) at 3 months. On binary logistic regression, sham stimulation was associated with greater odds of developing spasticity at 1 month (shoulder odds ratio [OR], 8.29 [95% CI, 1.95–35.27],P=0.04; elbow OR, 7.62 [95% CI, 1.69–34.35],P=0.08; wrist OR, 5.18 [95% CI, 1.60–16.78],P=0.06). At 3 months, sham stimulation remained predictive, with higher odds of spasticity at the shoulder (OR, 15.3 [95% CI, 8.26–28.43]), elbow (OR, 13.43 [95% CI, 3.94–45.78]), wrist (OR, 19.9 [95% CI, 4.9–80.96]), and fingers (OR, 26.25 [95% CI, 5.19–132.87], allP=0.001). Minor adverse events like headache and light-headedness were observed in 5 patients.CONCLUSIONS:Low-frequency rTMS over contralesional primary motor cortex significantly prevented spasticity, improved motor recovery, reduced pain, improved functional outcomes and quality of life in early subacute stroke, supporting its role as a promising adjunctive therapy in early stroke rehabilitation.REGISTRATION:URL:https://ctri.nic.in/; Unique identifier: CTRI/2024/01/061225.
引用
- Stroke:Efficacy of Repetitive Transcranial Magnetic Stimulation in Preventing Poststroke Spasticity: A Sham-Controlled Trial
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。